Income Statement Acrux Limited

Stocks

ACR

AU000000ACR3

Pharmaceuticals

Delayed Australian S.E. 19:59:11 2026-08-16 EDT			5-day change	1st Jan Change
0.0100 ^AUD	0.00%		0.00%	-33.33%

08-17	Acrux Limited - Special Call
05-27	Acrux licenses Lenzetto for Australian market for A$5.4 million	RE

d74b62d4b06d7af.rgDVjFjN5v9PC-NCVp2FTipWjnuJRPjWfJ4uMWOJLuA.wGyY_Cq6rNJ3YNp7Mtb_JUkyoxD7IJ2xH9RYVlfFTdH_Rb74FITepis4pg

Published financial data: ACRUX LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	1.34M	1.72M	8.43M	5.09M	1.19M
Total Revenues	1.34M	1.72M	8.43M	5.09M	1.19M
Cost of Goods Sold, Total	8.93M	6.37M	4.37M	6.38M	2.31M
Gross Profit	-7.59M	-4.65M	4.06M	-1.28M	-1.12M
Selling General & Admin Expenses, Total	6.49M	6.08M	5.74M	5.75M	5.91M
Stock-Based Compensation (IS)	507K	450K	370K	381K	216K
Depreciation & Amortization - (IS)	665K	660K	595K	510K	467K
Other Operating Expenses	995K	1.12M	748K	649K	1.26M
Other Operating Expenses, Total	8.66M	8.31M	7.45M	7.29M	7.85M
Operating Income	-16.25M	-12.97M	-3.39M	-8.58M	-8.97M
Interest Expense, Total	-	-	-	-	-303K
Interest And Investment Income	34K	18K	122K	134K	40K
Net Interest Expenses	34K	18K	122K	134K	-263K
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	3.78M	3.37M	3.38M	2.87M	3.3M
EBT, Excl. Unusual Items	-12.43M	-9.58M	109K	-5.57M	-5.94M
Asset Writedown	-	-	-321K	-	-
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	-12.43M	-9.58M	-212K	-5.57M	-5.94M
Income Tax Expense	197K	252K	552K	232K	8K
Earnings From Continuing Operations	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Net Income to Company	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Net Income - (IS)	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Net Income to Common Incl Extra Items	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Net Income to Common Excl. Extra Items	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Per Share Items
Net EPS - Basic	-0.06	-0.03	-0	-0.02	-0.02
Basic EPS - Continuing Operations	-0.06	-0.03	-0	-0.02	-0.02
Basic Weighted Average Shares Outstanding	220M	284M	286M	289M	352M
Net EPS - Diluted	-0.06	-0.03	-0	-0.02	-0.02
Diluted EPS - Continuing Operations	-0.06	-0.03	-0	-0.02	-0.02
Diluted Weighted Average Shares Outstanding	220M	284M	286M	289M	352M
Normalized Basic EPS	-0.04	-0.02	0	-0.01	-0.01
Normalized Diluted EPS	-0.04	-0.02	0	-0.01	-0.01
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-15.93M	-12.61M	-2.81M	-8.34M	-8.76M
EBITA	-16.25M	-12.97M	-3.39M	-8.58M	-8.97M
EBIT	-16.25M	-12.97M	-3.39M	-8.58M	-8.97M
EBITDAR	-15.68M	-12.41M	-2.56M	-8.06M	-8.51M
Total Revenues (As Reported)	5.16M	5.1M	11.93M	8.1M	4.53M
Effective Tax Rate - (Ratio)	-1.58	-2.63	-260.38	-4.17	-0.13
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	197K	252K	552K	232K	8K
Normalized Net Income	-7.77M	-5.99M	68.12K	-3.48M	-3.71M
Interest on Long-Term Debt	185K	172K	196K	178K	163K
Supplemental Operating Expense Items
General and Administrative Expenses	828K	639K	532K	555K	569K
Research And Development Expense From Footnotes	9.04M	6.48M	3.86M	2.42M	2.31M
Net Rental Expense, Total	247K	201K	244K	281K	248K
Imputed Operating Lease Interest Expense	-	-	-	-	164K
Imputed Operating Lease Depreciation	-	-	-	-	84.18K
Stock-Based Comp., Other (Total)	507K	450K	370K	381K	216K
Total Stock-Based Compensation	507K	450K	370K	381K	216K

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	15.27M	5.83M	6.23M	2.94M	863K
Total Cash And Short Term Investments	15.27M	5.83M	6.23M	2.94M	863K
Accounts Receivable, Total	288K	262K	385K	4K	719K
Other Receivables	2.87M	3.5M	2.92M	2.88M	3.07M
Total Receivables	3.16M	3.76M	3.31M	2.89M	3.79M
Prepaid Expenses	165K	420K	316K	147K	149K
Other Current Assets, Total	-	-	37K	-	-
Total Current Assets	18.59M	10.02M	9.89M	5.98M	4.8M
Gross Property Plant And Equipment	4.51M	4.92M	5.49M	5.77M	5.59M
Accumulated Depreciation	-1.87M	-2.36M	-2.9M	-3.36M	-3.74M
Net Property Plant And Equipment	2.64M	2.56M	2.59M	2.41M	1.86M
Other Intangibles, Total	-	-	-	-	-
Deferred Tax Assets Long-Term	1.61M	1.36M	803K	572K	564K
Deferred Charges Long-Term	482K	375K	-	-	-
Total Assets	23.33M	14.3M	13.28M	8.96M	7.22M
Liabilities
Accounts Payable, Total	312K	789K	488K	427K	463K
Accrued Expenses, Total	801K	875K	826K	868K	907K
Short-term Borrowings	-	-	-	1.49M	1.73M
Current Portion of Leases	185K	224K	192K	293K	225K
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	1.47M	1.43M	884K	647K	1.16M
Total Current Liabilities	2.77M	3.32M	2.39M	3.72M	4.48M
Long-Term Leases	2.05M	1.85M	2.16M	1.92M	1.68M
Pension & Other Post Retirement Benefits	41K	40K	38K	41K	39K
Deferred Tax Liability Non Current	-	-	-	-	-
Total Liabilities	4.86M	5.21M	4.59M	5.69M	6.2M
Common Stock, Total	114M	115M	115M	115M	118M
Retained Earnings	-96.5M	-106M	-107M	-5.8M	-119M
Comprehensive Income and Other	757K	860K	909K	-106M	1.65M
Total Common Equity	18.47M	9.09M	8.7M	3.28M	1.02M
Total Equity	18.47M	9.09M	8.7M	3.28M	1.02M
Total Liabilities And Equity	23.33M	14.3M	13.28M	8.96M	7.22M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	283M	285M	288M	291M	409M
ECS Total Common Shares Outstanding	283M	285M	288M	291M	408M
Book Value / Share	0.07	0.03	0.03	0.01	0
Tangible Book Value	18.47M	9.09M	8.7M	3.28M	1.02M
Tangible Book Value Per Share	0.07	0.03	0.03	0.01	0
Total Debt	2.23M	2.08M	2.35M	3.7M	3.64M
Net Debt	-13.04M	-3.75M	-3.88M	759K	2.77M
Debt Equivalent Oper. Leases	1.98M	1.61M	1.95M	2.25M	1.98M
Account Code - Inventory Valuation	3	3	-	3	3
Machinery, Total	1.92M	2.32M	2.49M	2.67M	2.72M

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	-12.63M	-9.83M	-764K	-5.8M	-5.94M
Depreciation & Amortization - CF	557K	553K	863K	510K	467K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	557K	553K	863K	510K	467K
Amortization of Deferred Charges, Total - (CF)	107K	107K	53K	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	507K	450K	370K	381K	216K
Other Operating Activities, Total	-	-	-	-	-
Change In Accounts Receivable	-600K	-606K	459K	417K	-903K
Change In Accounts Payable	-103K	441K	-847K	-294K	411K
Change In Income Taxes	-	-	-	-	-
Change In Deferred Taxes	197K	252K	552K	232K	8K
Change in Other Net Operating Assets	550K	-182K	17K	251K	275K
Cash from Operations	-11.41M	-8.82M	703K	-4.3M	-5.47M
Capital Expenditure	-102K	-465K	-119K	-276K	-5K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash from Investing	-102K	-465K	-119K	-276K	-5K
Short Term Debt Issued, Total	-	-	-	1.49M	2.19M
Total Debt Issued	-	-	-	1.49M	2.19M
Short Term Debt Repaid, Total	-	-	-	-	-1.96M
Long-Term Debt Repaid, Total	-167K	-155K	-183K	-195K	-217K
Total Debt Repaid	-167K	-155K	-183K	-195K	-2.18M
Issuance of Common Stock	17.75M	-	-	-	3.38M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	17.58M	-155K	-183K	1.29M	3.39M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	6.06M	-9.44M	401K	-3.29M	-2.08M
Supplemental Items
Cash Interest Paid	185K	172K	201K	179K	238K
Cash Income Tax Paid (Refund)	-2.92M	-3.11M	-3.73M	-2.87M	-2.98M
Levered Free Cash Flow	-9.19M	-7.81M	-1.32M	-4.38M	-5.44M
Unlevered Free Cash Flow	-9.19M	-7.81M	-1.32M	-4.38M	-5.25M
Change In Net Working Capital	105K	348K	370K	-367K	318K
Net Debt Issued / Repaid	-167K	-155K	-183K	1.29M	18K

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	-49.35	-43.07	-15.36	-48.18	-69.27
Return on Total Capital	-56.5	-50.85	-19.07	-59.45	-96.35
Return On Equity %	-80.64	-71.36	-8.59	-96.89	-276.58
Return on Common Equity	-80.64	-71.36	-8.59	-96.89	-276.58
Margin Analysis
Gross Profit Margin %	-567.76	-270.62	48.16	-25.22	-93.95
SG&A Margin	485.64	353.98	68.05	112.96	496.64
EBITDA Margin %	-1.19K	-733.74	-33.33	-163.74	-735.88
EBITA Margin %	-1.22K	-754.28	-40.22	-168.43	-753.87
EBIT Margin %	-1.22K	-754.28	-40.22	-168.43	-753.87
Income From Continuing Operations Margin %	-944.58	-572.08	-9.06	-113.93	-499.58
Net Income Margin %	-944.58	-572.08	-9.06	-113.93	-499.58
Net Avail. For Common Margin %	-944.58	-572.08	-9.06	-113.93	-499.58
Normalized Net Income Margin	-581.15	-348.39	0.81	-68.36	-311.82
Levered Free Cash Flow Margin	-687.57	-454.14	-15.68	-85.98	-456.83
Unlevered Free Cash Flow Margin	-687.57	-454.14	-15.68	-85.98	-440.91
Asset Turnover
Asset Turnover	0.06	0.09	0.61	0.46	0.15
Fixed Assets Turnover	0.47	0.66	3.28	2.04	0.56
Receivables Turnover (Average Receivables)	5.59	6.25	26.06	26.17	3.29
Short Term Liquidity
Current Ratio	6.72	3.02	4.14	1.61	1.07
Quick Ratio	6.66	2.89	3.99	1.57	1.04
Operating Cash Flow to Current Liabilities	-4.13	-2.66	0.29	-1.16	-1.22
Days Sales Outstanding (Average Receivables)	65.25	58.39	14.01	13.98	110.88
Average Days Payable Outstanding	27.33	31.54	53.33	26.27	70.37
Long Term Solvency
Total Debt/Equity	12.09	22.86	27.06	113.06	355.33
Total Debt / Total Capital	10.79	18.61	21.3	53.07	78.04
LT Debt/Equity	11.09	20.4	24.85	58.73	164.52
Long-Term Debt / Total Capital	9.9	16.6	19.56	27.56	36.13
Total Liabilities / Total Assets	20.82	36.44	34.54	63.45	85.84
EBIT / Interest Expense	-	-	-	-	-29.61
EBITDA / Interest Expense	-	-	-	-	-28.07
(EBITDA - Capex) / Interest Expense	-	-	-	-	-28.08
Total Debt / EBITDA	-0.14	-0.17	-0.93	-0.46	-0.43
Net Debt / EBITDA	0.83	0.3	1.54	-0.09	-0.33
Total Debt / (EBITDA - Capex)	-0.14	-0.16	-0.89	-0.44	-0.43
Net Debt / (EBITDA - Capex)	0.83	0.29	1.47	-0.09	-0.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.7	28.57	390.34	-39.6	-76.63
Gross Profit, 1 Yr. Growth %	101.94	-38.72	-187.25	-131.63	-12.93
EBITDA, 1 Yr. Growth %	36.4	-20.81	-77.73	166.33	7.33
EBITA, 1 Yr. Growth %	34.56	-20.21	-73.85	152.95	6.82
EBIT, 1 Yr. Growth %	34.56	-20.21	-73.85	152.95	6.82
Earnings From Cont. Operations, 1 Yr. Growth %	33.34	-22.13	-92.23	659.16	2.5
Net Income, 1 Yr. Growth %	33.34	-22.13	-92.23	659.16	2.5
Normalized Net Income, 1 Yr. Growth %	32.47	-25.12	-101.14	-5.21K	6.63
Diluted EPS Before Extra, 1 Yr. Growth %	1.77	-39.75	-92.21	642	-15.65
Accounts Receivable, 1 Yr. Growth %	51.58	-9.03	46.95	-98.96	17.88K
Net Property, Plant and Equip., 1 Yr. Growth %	-14.71	-3.33	1.37	-6.99	-22.9
Total Assets, 1 Yr. Growth %	30.79	-38.69	-7.11	-32.53	-19.39
Tangible Book Value, 1 Yr. Growth %	43.75	-50.79	-4.33	-62.33	-68.77
Common Equity, 1 Yr. Growth %	43.75	-50.79	-4.33	-62.33	-68.77
Cash From Operations, 1 Yr. Growth %	33.76	-22.74	-107.97	-712.09	27.14
Capital Expenditures, 1 Yr. Growth %	-60.47	355.88	-74.41	131.93	-98.19
Levered Free Cash Flow, 1 Yr. Growth %	31.72	-15.08	-83.07	166.47	24.17
Unlevered Free Cash Flow, 1 Yr. Growth %	31.72	-15.08	-83.07	166.47	22.97
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.56	17.13	151.09	72.09	-62.43
Gross Profit, 2 Yr. CAGR %	30	11.25	-26.88	-47.46	-47.52
EBITDA, 2 Yr. CAGR %	12.11	3.93	-58	-18.7	67.27
EBITA, 2 Yr. CAGR %	11.85	3.62	-54.33	-18.68	62.67
EBIT, 2 Yr. CAGR %	11.85	3.62	-54.33	-18.68	62.67
Earnings From Cont. Operations, 2 Yr. CAGR %	23.17	1.9	-75.4	-23.2	178.95
Net Income, 2 Yr. CAGR %	23.17	1.9	-75.4	-23.2	178.95
Normalized Net Income, 2 Yr. CAGR %	22.13	1.04	-90.77	-23.77	638.02
Diluted EPS Before Extra, 2 Yr. CAGR %	7.24	-21.7	-78.33	-23.95	150.18
Accounts Receivable, 2 Yr. CAGR %	20.6	17.43	15.62	-87.64	36.66
Net Property, Plant and Equip., 2 Yr. CAGR %	70.83	-9.2	-1.01	-2.9	-15.32
Total Assets, 2 Yr. CAGR %	-2.29	-10.45	-24.53	-20.84	-26.25
Tangible Book Value, 2 Yr. CAGR %	-8.24	-15.89	-31.39	-39.97	-65.7
Common Equity, 2 Yr. CAGR %	-8.24	-15.89	-31.39	-39.97	-65.7
Cash From Operations, 2 Yr. CAGR %	7.17	1.66	-75.18	-30.15	178.97
Capital Expenditures, 2 Yr. CAGR %	-48.19	34.25	8.01	-22.96	-79.5
Levered Free Cash Flow, 2 Yr. CAGR %	-4.85	5.76	-62.08	-25.12	81.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.85	5.76	-62.08	-25.12	78.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-26.97	39.66	88.77	56.16	-11.54
Gross Profit, 3 Yr. CAGR %	348.75	1.17	2.59	-44.7	-37.83
EBITDA, 3 Yr. CAGR %	19.52	-0.15	-37.81	-19.41	-11.45
EBITA, 3 Yr. CAGR %	19.36	-0.06	-34.52	-19.19	-11.55
EBIT, 3 Yr. CAGR %	19.36	-0.06	-34.52	-19.19	-11.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.79	5.71	-56.79	-22.85	-15.44
Net Income, 3 Yr. CAGR %	-3.79	5.71	-56.79	-22.85	-15.44
Normalized Net Income, 3 Yr. CAGR %	8.44	4.76	-77.35	-24.22	-14.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-12.29	-11.51	-63.71	-29.63	-21.28
Accounts Receivable, 3 Yr. CAGR %	22.94	9.79	26.54	-75.96	40
Net Property, Plant and Equip., 3 Yr. CAGR %	46.26	41.3	-5.8	-3.04	-10.09
Total Assets, 3 Yr. CAGR %	-10.46	-16.35	-9.35	-27.3	-20.36
Tangible Book Value, 3 Yr. CAGR %	-14.9	-25.45	-12.2	-43.82	-51.72
Common Equity, 3 Yr. CAGR %	-14.9	-25.45	-12.2	-43.82	-51.72
Cash From Operations, 3 Yr. CAGR %	29.28	-3.9	-56.49	-27.76	-14.71
Capital Expenditures, 3 Yr. CAGR %	-29.89	6.96	-22.74	39.35	-77.93
Levered Free Cash Flow, 3 Yr. CAGR %	98.85	-8.39	-42.57	-21.91	-11.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	98.85	-8.39	-42.57	-21.91	-12.41
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-45.79	-40.95	19.69	51.83	-1.03
Gross Profit, 5 Yr. CAGR %	-21.91	-25.71	117.18	-22.16	-21.54
EBITDA, 5 Yr. CAGR %	-3.49	2.37	-21.34	-8.03	-5.59
EBITA, 5 Yr. CAGR %	-3.03	3.15	-18.72	-7.97	-5.77
EBIT, 5 Yr. CAGR %	-2.94	3.26	-18.72	-7.97	-5.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.55	109.62	-44.25	-6.97	-8.89
Net Income, 5 Yr. CAGR %	-0.55	109.62	-44.25	-6.97	-8.89
Normalized Net Income, 5 Yr. CAGR %	-7.23	-1.97	-59.29	-7.75	-8.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.91	87.37	-49.86	-16.72	-21.45
Accounts Receivable, 5 Yr. CAGR %	-42.45	-45.58	19.96	-54.18	30.5
Net Property, Plant and Equip., 5 Yr. CAGR %	58.78	26.86	25.12	21.61	-9.73
Total Assets, 5 Yr. CAGR %	-15.26	-21.28	-16.38	-18.17	-16.53
Tangible Book Value, 5 Yr. CAGR %	-15.87	-27.03	-21.92	-31.63	-39.72
Common Equity, 5 Yr. CAGR %	-15.89	-27.03	-21.92	-31.63	-39.72
Cash From Operations, 5 Yr. CAGR %	-7.11	10.41	-33.19	-15.41	-8.51
Capital Expenditures, 5 Yr. CAGR %	-15.45	-5.86	-16.66	-6.2	-54.56
Levered Free Cash Flow, 5 Yr. CAGR %	-10.51	9.78	2.48	-15.49	-4.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	-10.51	9.78	2.48	-15.49	-5.55